Xytis
closedBiopharmaceutical company focusing on the discovery and development of innovative central nervous system drug candidates.
Launch date
Employees
Market cap
-
Enterprise valuation
€89—134m (Dealroom.co estimates Jan 2006.)
Company register number 05116784
Irvine California (HQ)
Authorizing premium user...